Clinical Trial Update: To Compare the Efficacy and Safety of Tripterygium (TW) Versus Valsartan in the Diabetic Nephropathy (DN) [NA]

View source ↗

Summary

Clinical trial comparing Tripterygium wilfordii to valsartan in diabetic nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• Tripterygium wilfordii (Tripterygium wilfordii)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Nanjing University School of Medicine | Conditions: Diabetic Nephropathy | NA | Status: COMPLETED